3 Spinal Muscular Atrophy Clinical Trials in Lancaster, CA (2026)

Q: How do I join a clinical trial in Lancaster?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you.

Recruiting Spinal Muscular Atrophy Studies in Lancaster

NCT04928846Recruiting

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues...

Lancaster, CAPHASE3768 participantsAbbVie

View Study Details

NCT07288034Recruiting

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

This phase II trial tests the impact of biomarkers in predicting initial treatment (first-line) PD1 or PD-L1 (PD\[L\]-1)-based immunotherapy response and in selecting second-line treatment in patients...

Lancaster, CAPHASE2535 participantsCity of Hope Medical Center

View Study Details

NCT04508790Recruiting

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

This phase II trial studies how well leflunomide, pomalidomide, and dexamethasone work for the treatment of multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory)...

Lancaster, CAPHASE229 participantsCity of Hope Medical Center

View Study Details

About Spinal Muscular Atrophy Clinical Trials in Lancaster

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 3 spinal muscular atrophy clinical trials recruiting participants in Lancaster, CA. These studies are seeking a combined 1,332 participants. Research is being sponsored by AbbVie, City of Hope Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Lancaster — FAQ

Are there spinal muscular atrophy clinical trials in Lancaster?

Yes, there are 3 spinal muscular atrophy clinical trials currently recruiting in Lancaster, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lancaster?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you about next steps.

Are clinical trials in Lancaster free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lancaster studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 3 active trials in Lancaster are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated October 17, 2026 from ClinicalTrials.gov